Dr. Leonard Appointed Senior Associate Dean for Innovation and Initiatives


Dr. John Leonard

Dr. John P. Leonard, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, has been appointed to Senior Associate Dean for Innovation and Initiatives. In this role, he will establish an office of entrepreneurship while working closely with senior leadership and investigators at Weill Cornell Medicine and from Cornell’s Ithaca campus, Cornell Tech, the Tri-Institutional community, and other partners. The WDOM congratulates Dr. Leonard on his new appointment.

Dr. Leonard is the Executive Vice Chair of the Weill Department of Medicine, a role in which he is advancing key educational and academic activities as well as other critical initiatives for the department. A nationally and internationally recognized authority on hematological malignancies, Dr. Leonard serves as the Associate Dean of Clinical Research at WCMC and leads the Joint Clinical Trials Office (JCTO) at WCM and NYP. The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Dr. Leonard has pioneered the development of novel therapeutics in lymphoma, and he serves as one of the leaders of the national lymphoma clinical trials effort as leader of the Lymphoma Committee for the Alliance for Clinical Trials in Oncology (a part of the National Clinical Trials Network of the National Cancer Institute). Dr. Leonard has been an elected member of the American Board of Internal Medicine subspecialty board for Hematology and has also been elected to membership in the American Society of Clinical Investigation. He has served as Chair of the Scientific Advisory Board and Board Member of the Lymphoma Research Foundation and Board Member of the Leukemia and Lymphoma Society/New York City Chapter. In 2017, he received the Miriam G. Wallach Award for Excellence in Humanistic Medical Care from New-York Presbyterian Hospital. Dr. Leonard has spearheaded many innovative initiatives in the Weill Department of Medicine to facilitate cutting-edge patient-oriented research.